MedPath
NMPA Approval

Potassium Aspartate Injection

国药准字H20133001

January 7, 2021

Drug Information

门冬氨酸钾注射液

注射剂

20ml:门冬氨酸钾3.424g

化学药品

January 7, 2021

Company Information

Applicant Company

本溪经济开发区香槐路122A

Manufacturing Company

本溪经济开发区香槐路122A

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

门冬氨酸钾注射液 - NMPA 批准文号 | MedPath